Dexamethasone Sodium Phosphate Injection — FDA Drug Shortage

No longer listed by FDA — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Dexamethasone Sodium Phosphate Injection (injection) from Fresenius Kabi USA, LLC with status No longer listed by FDA. The shortage was first posted on Feb 8, 2019. Reported reason: Demand increase for the drug

Shortage details

Status
No longer listed by FDA
Company
Fresenius Kabi USA, LLC
Package NDC
76045-106-10
Dosage Form
Injection
Presentation
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-106-10)
Initial Posting
Feb 8, 2019

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.